Derived from the expression 'securing health for all of us', CSL Seqirus has public health protection at its core.
At CSL Seqirus, Corporate Responsibility is about conducting our business ethically and contributing to the economic, social and environmental well-being of our communities.
CSL Seqirus is a transcontinental partner in pandemic preparedness and a major contributor to the prevention of influenza globally, with extensive research and production expertise and manufacturing plants in the US, UK and Australia.
CSL Seqirus is on the front line of battling influenza, working hard to suppress costly and life-threatening epidemics and pandemics. Vaccination is the most effective way to prevent influenza .
Our CSL Seqirus research and development group provides support to ensure the conditions are optimised for efficient vaccine manufacture. Activities also focus on improving the effectiveness of current influenza vaccines and their manufacturing processes.
At CSL Seqirus, we are committed to carrying out R&D in an ethical and transparent way as well as in accordance with government regulations and industry codes for good practice.
One of the largest influenza vaccine companies in the world, CSL Seqirus operates state-of-the-art manufacturing facilities in three different continents and a globally integrated supply chain for the timely supply of influenza vaccine to customers around the world.
CSL Seqirus utilises both egg and cell-based production technologies and we offer a broadest portfolio of influenza vaccines. We have commercialised the only adjuvanted seasonal influenza vaccine for older adults and paediatrics and offer two different types of quadrivalent influenza vaccines.
When you join CSL Seqirus, you join a team dedicated to protecting people and communities from influenza. It's a feeling of purpose and possibility that inspires us every day.
It doesn't matter whether you are a scientist or an administrator, a marketer or an operator - as long as you are inspired by the chance to create something that will help others, you can find your role at CSL Seqirus.
SHARING STORIES FROM THE FRONT LINE OF PUBLIC HEALTH
Why we can’t overlook influenza in the midst of the ongoing COVID-19 pandemic.
Influenza is constantly mutating. 70 years ago, the World Health Organization set up a surveillance network to protect people…
Families Fighting Flu’s president, Shelle Allen, shares her daughter’s story and why influenza is more than just a bad cold.
VP of Research Ethan Settembre discusses CSL’s new Massachusetts R&D hub and what it means for CSL’s Seqirus Business.
Seqirus Holly Springs recently cut the ribbon on an expansion to its fill-finish area, paramount to our ability to protect li…
Seqirus' former SVP of Research and Development reflects on his career and shares his thoughts on the future of CSL.
The biotech field saves lives through innovation. That's why Seqirus believes in investing in STEM’s next generation.
Jackson Free Clinic had trouble accessing flu vaccines, here's the story of how we made a difference.
We provide insights from the strain recommendation and share how we develop our seasonal vaccines.
Popular search terms: